spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

IRT Europe Summit

IRT_Europe_2018

10-11 April 2018
The Hotel Brussels, Belgium

New clinical trial regulations are requiring sponsors to keep tighter oversight than ever before – from audit trails to tracking system changes – resulting in high costs and trial delays. IRT Europe explores implementation best practices and how interactive response technologies can be utilised to improve supply chain planning and optimise clinical trials. Take this opportunity to share and discuss current industry needs, the latest tools and solutions for forecasting and the various regulatory requirements for IRT, among many other critical topics.

Pivotal Discussions, Unparalleled Insights and Expert Commentary Including:

  • Streamline IRT operations to ensure supply chain agility
  • Leverage end-to-end IRT for drug accountability and returns
  • Discuss the shift to standardisation to overcome challenges
    of building custom systems
  • Assess best practices for obtaining site feedback and
    leveraging it to drive simplicity in clinical trials
  • Explore the growing need for temperature monitoring
    of clinical supplies
  • Identify innovative approaches to integrate eSource
    and IRT to simplify the site experience
  • Facilitate web-based tools to expand IRT systems
    and avoid duplicate enrollment
  • Examine IRT and its role in patient randomisation
phone +1-339-298-2127
email Thomas.Zekos@cbinet.com
web www.cbinet.com/IRTEU
email The Hotel Brussels, Belgium
 
Print this page
Send to a friend
   
spacer
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>


White Papers

The Role of the CRO in Effective Risk-Based Monitoring

Medpace

The clinical trial industry is evolving. In an effort to improve participant safety and data integrity, regulators are encouraging trial sponsors to transition from a focused on-site monitoring approach they have traditionally employed toward a risk-based approach that utilizes a combination of centralized and on-site monitoring techniques to ensure patient safety and data quality. The Risk-Based Monitoring (RBM) paradigm has many potential advantages over established monitoring practices including enhanced patient safety and data integrity, more efficient and effective protocol design, reduced costs, and the ability to strategically adjust oversight in keeping with changes in risk level.
More info >>


News and Press Releases

3P Biopharmaceuticals and Nordic Nanovector have extended partnership for Betalutin® late stage manufacturing for B-cell non-Hodgkin lymphoma (NHL) treatment

The non-Hodgkin lymphoma (NHL) is a cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement